Symbol="ADXN"
AssetType="Common Stock"
Name="Addex Therapeutics Ltd"
Description="Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland."
CIK="1574232"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="CHEMIN DES MINES 9, GENEVA, CH"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="10032400"
EBITDA="-12737369"
PERatio="None"
PEGRatio="None"
BookValue="0.492"
DividendPerShare="0"
DividendYield="0"
EPS="-2.36"
RevenuePerShareTTM="0.216"
ProfitMargin="0"
OperatingMarginTTM="-5.87"
ReturnOnAssetsTTM="-0.773"
ReturnOnEquityTTM="-1.977"
RevenueTTM="2148600"
GrossProfitTTM="1445000"
DilutedEPSTTM="-2.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.39"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.28"
PriceToBookRatio="1.409"
EVToRevenue="2.539"
EVToEBITDA="-0.147"
Beta="1.636"
num_52WeekHigh="2.28"
num_52WeekLow="0.422"
num_50DayMovingAverage="0.592"
num_200DayMovingAverage="0.863"
SharesOutstanding="16995700"
DividendDate="None"
ExDividendDate="None"
symbol="ADXN"
open="0.53"
high="0.53"
low="0.52"
price="0.52"
volume="459.00"
latest_trading_day="2023-08-18"
previous_close="0.53"
change="-0.01"
change_percent="-1.7565%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="94"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="6"
Volume_recent_avg="329473"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-2.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="6"
Aroon_momentum_negative="94"
image_negative_thumbnail_id_1="1122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_negative_thumbnail_id_2="174"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0002.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="996"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
